Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA
In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): 'Proposal for a Regulation on health technology assessment and amending Directive 2011/24/EU'. A number of stakeholders, including some Member States, welcomed this initiati...
Gespeichert in:
Veröffentlicht in: | EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH 2019-05, Vol.19 (3), p.251-261 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 261 |
---|---|
container_issue | 3 |
container_start_page | 251 |
container_title | EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH |
container_volume | 19 |
creator | Bonanno, Patricia Vella Bucsics, Anna Simoens, Steven Martin, Antony P Oortwijn, Wija Gulbinovic, Jolanta Rothe, Celia Timoney, Angela Ferrario, Alessandra Gad, Mohamed Salem, Ahmed Hoxha, Iris Sauermann, Robert Kamusheva, Maria Dimitrova, Maria Petrova, Guenka Laius, Ott Selke, Gisbert Kourafalos, Vasilios Yfantopoulos, John Magnusson, Einar Joppi, Roberta Jakupi, Arianit Bochenek, Tomasz Wladysiuk, Magdalene Furtado, Claudia Markovic-Pekovic, Vanda Mardare, Ileana Meshkov, Dmitry Furst, Jurij Tomek, Dominik Cortadellas, Merce Obach Zara, Corrine Haycox, Alan Campbell, Stephen Godman, Brian |
description | In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): 'Proposal for a Regulation on health technology assessment and amending Directive 2011/24/EU'. A number of stakeholders, including some Member States, welcomed this initiative as it was considered to improve collaboration, reduce duplication and improve efficiency. There were however a number of concerns including its legal basis, the establishment of a single managing authority, the preservation of national jurisdiction over HTA decision-making and the voluntary/mandatory uptake of joint assessments by Member States. Areas covered: This paper presents the consolidated views and considerations on the original Proposal as set by the European Commission of a number of policy makers, payers, experts from pricing and reimbursement authorities and academics from across Europe. Expert commentary: The Proposal has since been extensively discussed at Council and while good progress has been achieved, there are still divergent positions. The European Parliament gave a number of recommendations for amendments. If the Proposal is approved, it is important that a balanced, improved outcome is achieved for all stakeholders. If not approved, the extensive contribution and progress attained should be sustained and preserved, and the best alternative solutions found. |
format | Article |
fullrecord | <record><control><sourceid>kuleuven_FZOIL</sourceid><recordid>TN_cdi_kuleuven_dspace_20_500_12942_699609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20_500_12942_699609</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_20_500_12942_6996093</originalsourceid><addsrcrecordid>eNqVi8tKxDAUQLtQcHT8h7sWK-mbLEVGZuli9uGS3kzjpEnITcV-gz9tBT9A4cDZnHNV7Kp2aMqh6oeb4pb5XYimlV23K77eUoiB0YEJCRASnReH2QYPGxOhyxNk0pMPLpxXQGZinslnsB4Oy3YTlBCi9dvDEAzE4KxeYcYLJX6EiOtmQD8CahxptprBpDBDngiMJTf-XMfT8764NuiY7n99Vzy8Hk4vx_KyOFo-yKuRI2pStVCdEKqqZVurXspeyOaf8dOfY5U_c_MNuGNk8A</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA</title><source>Lirias (KU Leuven Association)</source><creator>Bonanno, Patricia Vella ; Bucsics, Anna ; Simoens, Steven ; Martin, Antony P ; Oortwijn, Wija ; Gulbinovic, Jolanta ; Rothe, Celia ; Timoney, Angela ; Ferrario, Alessandra ; Gad, Mohamed ; Salem, Ahmed ; Hoxha, Iris ; Sauermann, Robert ; Kamusheva, Maria ; Dimitrova, Maria ; Petrova, Guenka ; Laius, Ott ; Selke, Gisbert ; Kourafalos, Vasilios ; Yfantopoulos, John ; Magnusson, Einar ; Joppi, Roberta ; Jakupi, Arianit ; Bochenek, Tomasz ; Wladysiuk, Magdalene ; Furtado, Claudia ; Markovic-Pekovic, Vanda ; Mardare, Ileana ; Meshkov, Dmitry ; Furst, Jurij ; Tomek, Dominik ; Cortadellas, Merce Obach ; Zara, Corrine ; Haycox, Alan ; Campbell, Stephen ; Godman, Brian</creator><creatorcontrib>Bonanno, Patricia Vella ; Bucsics, Anna ; Simoens, Steven ; Martin, Antony P ; Oortwijn, Wija ; Gulbinovic, Jolanta ; Rothe, Celia ; Timoney, Angela ; Ferrario, Alessandra ; Gad, Mohamed ; Salem, Ahmed ; Hoxha, Iris ; Sauermann, Robert ; Kamusheva, Maria ; Dimitrova, Maria ; Petrova, Guenka ; Laius, Ott ; Selke, Gisbert ; Kourafalos, Vasilios ; Yfantopoulos, John ; Magnusson, Einar ; Joppi, Roberta ; Jakupi, Arianit ; Bochenek, Tomasz ; Wladysiuk, Magdalene ; Furtado, Claudia ; Markovic-Pekovic, Vanda ; Mardare, Ileana ; Meshkov, Dmitry ; Furst, Jurij ; Tomek, Dominik ; Cortadellas, Merce Obach ; Zara, Corrine ; Haycox, Alan ; Campbell, Stephen ; Godman, Brian</creatorcontrib><description>In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): 'Proposal for a Regulation on health technology assessment and amending Directive 2011/24/EU'. A number of stakeholders, including some Member States, welcomed this initiative as it was considered to improve collaboration, reduce duplication and improve efficiency. There were however a number of concerns including its legal basis, the establishment of a single managing authority, the preservation of national jurisdiction over HTA decision-making and the voluntary/mandatory uptake of joint assessments by Member States. Areas covered: This paper presents the consolidated views and considerations on the original Proposal as set by the European Commission of a number of policy makers, payers, experts from pricing and reimbursement authorities and academics from across Europe. Expert commentary: The Proposal has since been extensively discussed at Council and while good progress has been achieved, there are still divergent positions. The European Parliament gave a number of recommendations for amendments. If the Proposal is approved, it is important that a balanced, improved outcome is achieved for all stakeholders. If not approved, the extensive contribution and progress attained should be sustained and preserved, and the best alternative solutions found.</description><identifier>ISSN: 1473-7167</identifier><language>eng</language><publisher>TAYLOR & FRANCIS LTD</publisher><ispartof>EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019-05, Vol.19 (3), p.251-261</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>316,781,27865</link.rule.ids><linktorsrc>$$Uhttps://lirias.kuleuven.be/handle/20.500.12942/699609$$EView_record_in_KU_Leuven_Association$$FView_record_in_$$GKU_Leuven_Association</linktorsrc></links><search><creatorcontrib>Bonanno, Patricia Vella</creatorcontrib><creatorcontrib>Bucsics, Anna</creatorcontrib><creatorcontrib>Simoens, Steven</creatorcontrib><creatorcontrib>Martin, Antony P</creatorcontrib><creatorcontrib>Oortwijn, Wija</creatorcontrib><creatorcontrib>Gulbinovic, Jolanta</creatorcontrib><creatorcontrib>Rothe, Celia</creatorcontrib><creatorcontrib>Timoney, Angela</creatorcontrib><creatorcontrib>Ferrario, Alessandra</creatorcontrib><creatorcontrib>Gad, Mohamed</creatorcontrib><creatorcontrib>Salem, Ahmed</creatorcontrib><creatorcontrib>Hoxha, Iris</creatorcontrib><creatorcontrib>Sauermann, Robert</creatorcontrib><creatorcontrib>Kamusheva, Maria</creatorcontrib><creatorcontrib>Dimitrova, Maria</creatorcontrib><creatorcontrib>Petrova, Guenka</creatorcontrib><creatorcontrib>Laius, Ott</creatorcontrib><creatorcontrib>Selke, Gisbert</creatorcontrib><creatorcontrib>Kourafalos, Vasilios</creatorcontrib><creatorcontrib>Yfantopoulos, John</creatorcontrib><creatorcontrib>Magnusson, Einar</creatorcontrib><creatorcontrib>Joppi, Roberta</creatorcontrib><creatorcontrib>Jakupi, Arianit</creatorcontrib><creatorcontrib>Bochenek, Tomasz</creatorcontrib><creatorcontrib>Wladysiuk, Magdalene</creatorcontrib><creatorcontrib>Furtado, Claudia</creatorcontrib><creatorcontrib>Markovic-Pekovic, Vanda</creatorcontrib><creatorcontrib>Mardare, Ileana</creatorcontrib><creatorcontrib>Meshkov, Dmitry</creatorcontrib><creatorcontrib>Furst, Jurij</creatorcontrib><creatorcontrib>Tomek, Dominik</creatorcontrib><creatorcontrib>Cortadellas, Merce Obach</creatorcontrib><creatorcontrib>Zara, Corrine</creatorcontrib><creatorcontrib>Haycox, Alan</creatorcontrib><creatorcontrib>Campbell, Stephen</creatorcontrib><creatorcontrib>Godman, Brian</creatorcontrib><title>Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA</title><title>EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH</title><description>In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): 'Proposal for a Regulation on health technology assessment and amending Directive 2011/24/EU'. A number of stakeholders, including some Member States, welcomed this initiative as it was considered to improve collaboration, reduce duplication and improve efficiency. There were however a number of concerns including its legal basis, the establishment of a single managing authority, the preservation of national jurisdiction over HTA decision-making and the voluntary/mandatory uptake of joint assessments by Member States. Areas covered: This paper presents the consolidated views and considerations on the original Proposal as set by the European Commission of a number of policy makers, payers, experts from pricing and reimbursement authorities and academics from across Europe. Expert commentary: The Proposal has since been extensively discussed at Council and while good progress has been achieved, there are still divergent positions. The European Parliament gave a number of recommendations for amendments. If the Proposal is approved, it is important that a balanced, improved outcome is achieved for all stakeholders. If not approved, the extensive contribution and progress attained should be sustained and preserved, and the best alternative solutions found.</description><issn>1473-7167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqVi8tKxDAUQLtQcHT8h7sWK-mbLEVGZuli9uGS3kzjpEnITcV-gz9tBT9A4cDZnHNV7Kp2aMqh6oeb4pb5XYimlV23K77eUoiB0YEJCRASnReH2QYPGxOhyxNk0pMPLpxXQGZinslnsB4Oy3YTlBCi9dvDEAzE4KxeYcYLJX6EiOtmQD8CahxptprBpDBDngiMJTf-XMfT8764NuiY7n99Vzy8Hk4vx_KyOFo-yKuRI2pStVCdEKqqZVurXspeyOaf8dOfY5U_c_MNuGNk8A</recordid><startdate>20190504</startdate><enddate>20190504</enddate><creator>Bonanno, Patricia Vella</creator><creator>Bucsics, Anna</creator><creator>Simoens, Steven</creator><creator>Martin, Antony P</creator><creator>Oortwijn, Wija</creator><creator>Gulbinovic, Jolanta</creator><creator>Rothe, Celia</creator><creator>Timoney, Angela</creator><creator>Ferrario, Alessandra</creator><creator>Gad, Mohamed</creator><creator>Salem, Ahmed</creator><creator>Hoxha, Iris</creator><creator>Sauermann, Robert</creator><creator>Kamusheva, Maria</creator><creator>Dimitrova, Maria</creator><creator>Petrova, Guenka</creator><creator>Laius, Ott</creator><creator>Selke, Gisbert</creator><creator>Kourafalos, Vasilios</creator><creator>Yfantopoulos, John</creator><creator>Magnusson, Einar</creator><creator>Joppi, Roberta</creator><creator>Jakupi, Arianit</creator><creator>Bochenek, Tomasz</creator><creator>Wladysiuk, Magdalene</creator><creator>Furtado, Claudia</creator><creator>Markovic-Pekovic, Vanda</creator><creator>Mardare, Ileana</creator><creator>Meshkov, Dmitry</creator><creator>Furst, Jurij</creator><creator>Tomek, Dominik</creator><creator>Cortadellas, Merce Obach</creator><creator>Zara, Corrine</creator><creator>Haycox, Alan</creator><creator>Campbell, Stephen</creator><creator>Godman, Brian</creator><general>TAYLOR & FRANCIS LTD</general><scope>FZOIL</scope></search><sort><creationdate>20190504</creationdate><title>Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA</title><author>Bonanno, Patricia Vella ; Bucsics, Anna ; Simoens, Steven ; Martin, Antony P ; Oortwijn, Wija ; Gulbinovic, Jolanta ; Rothe, Celia ; Timoney, Angela ; Ferrario, Alessandra ; Gad, Mohamed ; Salem, Ahmed ; Hoxha, Iris ; Sauermann, Robert ; Kamusheva, Maria ; Dimitrova, Maria ; Petrova, Guenka ; Laius, Ott ; Selke, Gisbert ; Kourafalos, Vasilios ; Yfantopoulos, John ; Magnusson, Einar ; Joppi, Roberta ; Jakupi, Arianit ; Bochenek, Tomasz ; Wladysiuk, Magdalene ; Furtado, Claudia ; Markovic-Pekovic, Vanda ; Mardare, Ileana ; Meshkov, Dmitry ; Furst, Jurij ; Tomek, Dominik ; Cortadellas, Merce Obach ; Zara, Corrine ; Haycox, Alan ; Campbell, Stephen ; Godman, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_20_500_12942_6996093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonanno, Patricia Vella</creatorcontrib><creatorcontrib>Bucsics, Anna</creatorcontrib><creatorcontrib>Simoens, Steven</creatorcontrib><creatorcontrib>Martin, Antony P</creatorcontrib><creatorcontrib>Oortwijn, Wija</creatorcontrib><creatorcontrib>Gulbinovic, Jolanta</creatorcontrib><creatorcontrib>Rothe, Celia</creatorcontrib><creatorcontrib>Timoney, Angela</creatorcontrib><creatorcontrib>Ferrario, Alessandra</creatorcontrib><creatorcontrib>Gad, Mohamed</creatorcontrib><creatorcontrib>Salem, Ahmed</creatorcontrib><creatorcontrib>Hoxha, Iris</creatorcontrib><creatorcontrib>Sauermann, Robert</creatorcontrib><creatorcontrib>Kamusheva, Maria</creatorcontrib><creatorcontrib>Dimitrova, Maria</creatorcontrib><creatorcontrib>Petrova, Guenka</creatorcontrib><creatorcontrib>Laius, Ott</creatorcontrib><creatorcontrib>Selke, Gisbert</creatorcontrib><creatorcontrib>Kourafalos, Vasilios</creatorcontrib><creatorcontrib>Yfantopoulos, John</creatorcontrib><creatorcontrib>Magnusson, Einar</creatorcontrib><creatorcontrib>Joppi, Roberta</creatorcontrib><creatorcontrib>Jakupi, Arianit</creatorcontrib><creatorcontrib>Bochenek, Tomasz</creatorcontrib><creatorcontrib>Wladysiuk, Magdalene</creatorcontrib><creatorcontrib>Furtado, Claudia</creatorcontrib><creatorcontrib>Markovic-Pekovic, Vanda</creatorcontrib><creatorcontrib>Mardare, Ileana</creatorcontrib><creatorcontrib>Meshkov, Dmitry</creatorcontrib><creatorcontrib>Furst, Jurij</creatorcontrib><creatorcontrib>Tomek, Dominik</creatorcontrib><creatorcontrib>Cortadellas, Merce Obach</creatorcontrib><creatorcontrib>Zara, Corrine</creatorcontrib><creatorcontrib>Haycox, Alan</creatorcontrib><creatorcontrib>Campbell, Stephen</creatorcontrib><creatorcontrib>Godman, Brian</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bonanno, Patricia Vella</au><au>Bucsics, Anna</au><au>Simoens, Steven</au><au>Martin, Antony P</au><au>Oortwijn, Wija</au><au>Gulbinovic, Jolanta</au><au>Rothe, Celia</au><au>Timoney, Angela</au><au>Ferrario, Alessandra</au><au>Gad, Mohamed</au><au>Salem, Ahmed</au><au>Hoxha, Iris</au><au>Sauermann, Robert</au><au>Kamusheva, Maria</au><au>Dimitrova, Maria</au><au>Petrova, Guenka</au><au>Laius, Ott</au><au>Selke, Gisbert</au><au>Kourafalos, Vasilios</au><au>Yfantopoulos, John</au><au>Magnusson, Einar</au><au>Joppi, Roberta</au><au>Jakupi, Arianit</au><au>Bochenek, Tomasz</au><au>Wladysiuk, Magdalene</au><au>Furtado, Claudia</au><au>Markovic-Pekovic, Vanda</au><au>Mardare, Ileana</au><au>Meshkov, Dmitry</au><au>Furst, Jurij</au><au>Tomek, Dominik</au><au>Cortadellas, Merce Obach</au><au>Zara, Corrine</au><au>Haycox, Alan</au><au>Campbell, Stephen</au><au>Godman, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA</atitle><jtitle>EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH</jtitle><date>2019-05-04</date><risdate>2019</risdate><volume>19</volume><issue>3</issue><spage>251</spage><epage>261</epage><pages>251-261</pages><issn>1473-7167</issn><abstract>In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): 'Proposal for a Regulation on health technology assessment and amending Directive 2011/24/EU'. A number of stakeholders, including some Member States, welcomed this initiative as it was considered to improve collaboration, reduce duplication and improve efficiency. There were however a number of concerns including its legal basis, the establishment of a single managing authority, the preservation of national jurisdiction over HTA decision-making and the voluntary/mandatory uptake of joint assessments by Member States. Areas covered: This paper presents the consolidated views and considerations on the original Proposal as set by the European Commission of a number of policy makers, payers, experts from pricing and reimbursement authorities and academics from across Europe. Expert commentary: The Proposal has since been extensively discussed at Council and while good progress has been achieved, there are still divergent positions. The European Parliament gave a number of recommendations for amendments. If the Proposal is approved, it is important that a balanced, improved outcome is achieved for all stakeholders. If not approved, the extensive contribution and progress attained should be sustained and preserved, and the best alternative solutions found.</abstract><pub>TAYLOR & FRANCIS LTD</pub></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1473-7167 |
ispartof | EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019-05, Vol.19 (3), p.251-261 |
issn | 1473-7167 |
language | eng |
recordid | cdi_kuleuven_dspace_20_500_12942_699609 |
source | Lirias (KU Leuven Association) |
title | Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T11%3A41%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven_FZOIL&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proposal%20for%20a%20regulation%20on%20health%20technology%20assessment%20in%20Europe%20-%20opinions%20of%20policy%20makers,%20payers%20and%20academics%20from%20the%20field%20of%20HTA&rft.jtitle=EXPERT%20REVIEW%20OF%20PHARMACOECONOMICS%20&%20OUTCOMES%20RESEARCH&rft.au=Bonanno,%20Patricia%20Vella&rft.date=2019-05-04&rft.volume=19&rft.issue=3&rft.spage=251&rft.epage=261&rft.pages=251-261&rft.issn=1473-7167&rft_id=info:doi/&rft_dat=%3Ckuleuven_FZOIL%3E20_500_12942_699609%3C/kuleuven_FZOIL%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |